Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

March 16, 2015March 16, 2015

Rutgers Cancer Institute of New Jersey Specialist Addresses Dangers and Cessation Options for Smoking

Lung cancer News, News

The American Lung Association recently estimated that every day approximately 4,000 young people aged less than 18 years old smoke their first cigarette. This accounts for about 1.5 million youth ... Read more

March 13, 2015March 13, 2015

Definitive Concurrent Chemoradiation at High-volume Facilities Improves Survival in Patients with Advanced NSCLC

Lung cancer News, News

Findings from a recent study indicate that treatment at high-volume facilities is associated with improved overall survival among stage III NSCLC patients receiving definitive CCRT, independent of academic affiliation. The ... Read more

March 12, 2015March 12, 2015

Merrimack Pharmaceuticals Selects Patients for Experimental Drug Trial In NSCLC Patients

Lung cancer News, News

Advanced Cell Diagnostics, Inc. (ACD) a company that provides a sensitive and specific RNA hybridization technology, recently announced that Merrimack Pharmaceutical is utilizing their leading technology to choose participants for a ... Read more

March 6, 2015March 6, 2015

Lung Cancer Target Drugs Should Supplant Conventional Treatments by 2020

Lung cancer News, News

Although lung cancer is a leading cause of death worldwide, according to a recent analysis conducted by Frost & Sullivan titled “A Product and Pipeline Analysis of the Lung Cancer Therapeutics ... Read more

March 5, 2015March 5, 2015

FDA Grants Licensing Application To Opdivo For The Treatment Advanced Squamous NSCLC

News

Bristol-Myers Squibb recently announced that the FDA-provided Biologics Licensing Application (BLA) to Opdivo (nivolumab) to serve as treatment for advanced squamous non-small cell lung cancer (NSCLC) after earlier therapy. The company explores a ... Read more

March 4, 2015March 4, 2015

Regulation of SMARCA4 May Protect Against Lung Cancer

Lung cancer News, News

A recent study published in the current issue of the journal Human Molecular Genetics provided a better understanding of the molecular alterations during lung cancer development. The study titled “Expression inactivation of ... Read more

March 3, 2015March 3, 2015

Most Deaths in Australian Smokers Directly Attributed to Smoking

News

According to a recent study, in Australia up to two-thirds of deaths of current smokers can be attributed to their smoking habit. The study titled “Tobacco smoking and all-cause mortality in ... Read more

February 26, 2015February 26, 2015

Decline in Smoking Rates Indicates Decrease in Lung Cancer CT-Screening

News

Researchers at the Mayo Clinic recently identified that a decline in smoking rates may indicate that people suitable for CT-screening are not meeting eligibility criteria. The research titled “Trends in ... Read more

February 25, 2015February 25, 2015

Study Investigates Family Impact In Lung Cancer Decision-Making

Lung cancer News, News

A recent study found that specific factors impact family involvement in decisions regarding cancer patients’ treatment. The research, published in the Cancer journal, provides some insights that may help physicians ... Read more

February 24, 2015February 25, 2015

Crizotinib Associated With Systemic Intracranial Disease Control in ALK-Rearranged Non-Small Cell Lung Cancer

News

Researchers at the Beth Israel Deaconess Medical Center in Boston recently found that Crizotinib was associated with systemic and intracranial disease control in patients with ALK-rearranged non-small lung cancer who had brain ... Read more